NH - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 4.0
| Stock Code | NH | Market Cap | 39,315 Cr. | Current Price | 1,924 ₹ | High / Low | 2,372 ₹ |
| Stock P/E | 73.1 | Book Value | 127 ₹ | Dividend Yield | 0.23 % | ROCE | 19.8 % |
| ROE | 22.5 % | Face Value | 10.0 ₹ | DMA 50 | 1,814 ₹ | DMA 200 | 1,784 ₹ |
| Chg in FII Hold | -1.12 % | Chg in DII Hold | 1.23 % | PAT Qtr | 202 Cr. | PAT Prev Qtr | 109 Cr. |
| RSI | 58.7 | MACD | 37.3 | Volume | 2,87,018 | Avg Vol 1Wk | 6,70,445 |
| Low price | 1,564 ₹ | High price | 2,372 ₹ | PEG Ratio | 2.65 | Debt to equity | 0.76 |
| 52w Index | 44.5 % | Qtr Profit Var | 26.4 % | EPS | 24.6 ₹ | Industry PE | 47.0 |
📊 Analysis: NH shows strong intraday potential. Current price (₹1,924) is above DMA 50 (₹1,814) and DMA 200 (₹1,784), reflecting bullish momentum. RSI at 58.7 indicates healthy strength, while MACD (37.3) confirms strong positive bias. Volume (2.87L) is below the 1-week average (6.70L), showing reduced participation, but fundamentals remain solid with PAT growth (₹109 Cr → ₹202 Cr) and strong ROE/ROCE.
💹 Optimal Buy Price: ₹1,915–1,930 if sustained above VWAP with strong volume.
🎯 Profit Exit Levels: ₹1,950 (near resistance) and ₹1,975–2,000 (next resistance zone).
🛑 Stop-Loss: ₹1,890 (below intraday support).
⏱️ If Already Holding: Exit near ₹1,950–2,000 if RSI approaches 65–68 or momentum slows. Cut positions if price breaks below ₹1,890 with rising volume pressure.
Positive
- Strong ROE (22.5%) and ROCE (19.8%) highlight solid fundamentals.
- Quarterly PAT growth (+26.4%) boosts earnings momentum.
- Price trading above DMA 50 and DMA 200, confirming bullish bias.
- DII holding increased (+1.23%), showing strong domestic institutional support.
Limitation
- High P/E (73.1) compared to industry average (47.0), indicating overvaluation.
- Dividend yield at 0.23% is modest.
- Volume below average, reducing intraday conviction.
- Debt-to-equity ratio at 0.76 shows moderate leverage.
Company Negative News
- FII holding decreased (-1.12%), showing weaker foreign sentiment.
- High valuation may limit upside potential.
Company Positive News
- Quarterly PAT surged (₹109 Cr → ₹202 Cr).
- DII inflows (+1.23%) highlight strong domestic confidence.
- Price supported by DMA levels, confirming technical strength.
Industry
- Industry P/E at 47.0, lower than NH’s 73.1, suggesting premium valuation.
- Healthcare sector remains resilient with long-term demand drivers.
Conclusion
⚖️ NH offers strong intraday trading potential with bullish technicals and robust fundamentals but faces valuation pressure and weaker foreign sentiment. Suitable for trades above ₹1,915 with profit targets near ₹1,950–2,000 and strict stop-loss at ₹1,890. Momentum indicators suggest cautious optimism.
Would you like me to extend this into a swing trade analysis with 1–2 week holding logic, or keep it strictly intraday-focused?